The exclusion criteria were: females who were pregnant or experiencing a menstrual period, type 2 diabetes treated using an insulin regimen, malignancy, hematopathy, active tuberculosis, peptic ulcer with gastric bleeding, binge-eating disorder, psychiatric disease, congestive heart failure, clinically relevant renal or hepatic insufficiency, unstable coronary artery disease, cancer or a history of cancer
Sale is limited to researchers aged 21 years or older
There are no insurance requirements, and patients can pause, change, or cancel their treatment plan based on their needs and physician guidance
Why nutrition must not be overlooked in GLP-1 care Were proud to share an important article by BSLM Vice President Dr Ellen Fallows, published in The BMJ this month She highlights the urgent need for nutritional assessment and support as part of proper care for patients prescribed GLP-1 receptor agonists With food insecurity on the rise and diet quality declining, Dr Fallows warns that prescribing appetite-suppressing drugs without checking nutritional status could lead to serious health risks
